loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X

Information, Expiry & Status of FDA Orange Book Patents covering Bendamustine Hydrochloride

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CEPHALON (46)

02 EAGLE PHARMS (44)

03 SLAYBACK PHARMA LLC (1)

filter

01 8344006 (2)

02 8344006*PED (2)

03 8436190 (2)

04 8436190*PED (2)

05 8445524 (4)

06 8609707 (3)

07 8609863 (2)

08 8669279 (2)

09 8791270 (7)

10 8883836 (2)

11 8895756 (2)

12 9000021 (1)

13 9034908 (1)

14 9144568 (1)

15 9265831 (2)

16 9533955 (4)

17 10010533 (2)

18 10052385 (2)

19 11103483 (4)

20 11844783 (6)

21 11844784 (1)

22 11872214 (2)

23 8445524*PED (4)

24 8609863*PED (2)

25 8669279*PED (2)

26 8791270*PED (4)

27 8883836*PED (2)

28 8895756*PED (2)

29 9533955*PED (2)

30 9572796 (4)

31 9572797 (4)

32 9572887 (2)

33 9579384 (2)

34 9597397 (2)

35 9597398 (1)

36 9597399 (2)

filter

01 Y (4)

02 Blank (87)

filter

01 Y (43)

02 Blank (48)

filter

01 2026-01-12 (11)

02 2026-07-12 (8)

03 2029-03-26 (12)

04 2029-09-23 (2)

05 2029-09-26 (10)

06 2030-03-23 (2)

07 2030-10-26 (2)

08 2031-01-28 (24)

09 2031-04-26 (2)

10 2031-08-11 (3)

11 2033-03-15 (14)

12 2042-07-29 (1)

URL Supplier Web Content
8445524
Y
Y
2029-03-26
U-1402
22249
FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR INDOLENT B-CELL NON-HODGKIN LYMPHOMA (NHL)
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8791270
Y
2026-01-12
U-1542
22249
FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND/OR NON-HODGKINS LYMPHOMA
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8791270
Y
2026-01-12
U-1542
22249
FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND/OR NON-HODGKINS LYMPHOMA
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8883836
Y
2029-03-26
U-1402
22249
FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR INDOLENT B-CELL NON-HODGKIN LYMPHOMA (NHL)
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9533955
Y
2029-03-26
U-1952
22249
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9533955
Y
2029-03-26
U-1952
22249
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8791270
Y
2026-01-12
U-1542
22249
FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND/OR NON-HODGKINS LYMPHOMA
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8445524
Y
Y
2029-03-26
U-1402
22249
FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR INDOLENT B-CELL NON-HODGKIN LYMPHOMA (NHL)
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8791270
Y
2026-01-12
U-1542
22249
FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND/OR NON-HODGKINS LYMPHOMA
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8669279
Y
2029-03-26
U-1402
22249
FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR INDOLENT B-CELL NON-HODGKIN LYMPHOMA (NHL)
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY